Every so often you come across an idea that has so much merit you can’t imagine why somebody hadn’t come up with it before. Such is the case with hospital gowns matched to a patient’s skin color. Although sky blue and forest green might be stunning on the right patient, it is hard to imagine either one helping docs spot signs of diseases that can be found in skin color changes.
Every so often you come across an idea that has so much merit you can’t imagine why somebody hadn’t come up with it before. Such is the case with hospital gowns matched to a patient’s skin color. Although sky blue and forest green might be stunning on the right patient, it is hard to imagine either one helping docs spot signs of diseases that can be found in skin color changes.
Human eyes are hardwired to detect these changes, say the folks at Rensselaer Polytechnic Institute who came up with the new hospital garb. A blush, they point out, stands out when surrounded by regular-colored skin. Pale skin, yellow skin, and blue skin (indicative of a lack of blood oxygen, for example, always good for a doc to notice) are more apparent if the patient’s healthy color is draped across it, they argue.
It is that kind of thinking that may lead to a future generation of MR contrast agents. To date we’ve been looking at “enhanced” images in shades of gray. Researchers at Ohio State University are asking if maybe it’s time to colorize, not the MR images but the operating field.
They are at experimenting with nanoparticles that are both magnetic and fluorescent . These experimental bits of matter, measuring 20 nanometers across (for comparison’s sake, a sheet of paper is 100,000 nanometers thick), promise to enhance the appearance of tumors on MR scans, then light them up in green, for example, when the tumors themselves are exposed to black light during surgery.
This is one of those developments that won’t happen overnight. Animal tests haven’t even begun. But the idea is the product here, just as it is for skin-colored hospital gowns.
Radiology more than any other specialty is built on making the connection between diagnostic testing and disease as it actually occurs in the patient. Arguably, MR is successful for precisely this reason. Its images are intuitively recognizable, which is why radiologists were adopting MR long before its value was proven in clinical studies. Yet, in the nearly three decades since the commercialization of this modality, little more has been done to evolve the connection between disease seen in MR images and in the patient.
The Ohio State team has the right idea. We need to look for ways to make the presence of disease obvious. In that, we can take a lesson from the pioneers of skin-colored hospital gowns. It’s all about making disease stand out.
FDA Clears Virtually Helium-Free 1.5T MRI System from Siemens Healthineers
June 26th 2025Offering a cost- and resource-saving DryCool magnet technology, the Magnetom Flow.Ace MRI system reportedly requires 0.7 liters of liquid helium for cooling over the lifetime of the device in contrast to over 1,000 liters commonly utilized with conventional MRI platforms.
Multinational Study Reaffirms Value of Adjunctive AI for Prostate MRI
June 16th 2025The use of adjunctive AI in biparametric prostate MRI exams led to 3.3 percent and 3.4 percent increases in the AUC and specificity, respectively, for clinically significant prostate cancer (csPCa) in a 360-person cohort drawn from 53 facilities.
FDA Clears Enhanced MRI-Guided Laser Ablation System
June 5th 2025An alternative to an open neurosurgical approach, the Visualase V2 MRI-Guided Laser Ablation System reportedly utilizes laser interstitial thermal therapy (LITT) for targeted soft tissue ablation in patients with brain tumors and focal epilepsy.